Zdrowie i gospodarka · 10/03/2005

FDA Publishes Guidance for Drug Metabolizing Enzyme Genotyping Systems

The FDA has released a guidance document outlining requirements for drug metabolizing enzyme genotyping systems, which are now classified as Class II devices subject to special controls, and will remain subject to public comment.